Uganda Launches Ebola Vaccine Trial
The study will enroll 110 volunteers and assess whether an existing Ebola jab protects against the Bundibugyo strain.
6 Articles
6 Articles
Uganda launches Ebola vaccine trial
The town of Masaka in southern Uganda is currently conducting a Phase 1 trial of a vaccine candidate against the Bundibugyo strain of the Ebola virus, which is circulating in the region. There is currently no approved treatment or vaccine for this strain.
Oxford Mail
thisisoxfordshire.co.ukOxford-developed Ebola vaccine administered to volunteers in Uganda
Ugandan participants in a clinical safety study received an Oxford-developed Ebola vaccine last week.
Phase-1 trial of Ebola vaccine gets underway in Uganda
Scientists in the southern Ugandan city of Masaka are conducting a phase I trial of a candidate vaccine against the deadly Ebola Bundibugyo virus disease (BDBV), a strain for which no licensed vaccine or effective treatment currently exists.
Uganda begins human trial of vaccine against deadly Ebola strain - Rwanda Dispatch
Researchers in Uganda have begun a first-phase clinical trial of a candidate vaccine against the Bundibugyo strain of Ebola, which has caused a major outbreak in neighbouring Democratic Republic of Congo (DRC). The first participants received the vaccine on October 6 at a research site in Masaka City, southwestern Uganda, according to the University of […] The post Uganda begins human trial of vaccine against deadly Ebola strain appeared first o…
In Uganda, clinical trials of the Ebola Bundibudjo virus pilot vaccine, which caused a massive outbreak in the neighbouring Democratic Republic of the Congo, were initiated by students at Oxford University and the first volunteers were vaccinated on 6 October and reported to the educational press service.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
